Cargando…
The impact of the COVID-19 pandemic on the availability and implementation of cytoreductive surgery and HIPEC in patients with peritoneal carcinomatosis at the Wroclaw Comprehensive Cancer Center
Autores principales: | Szewczyk, Krzysztof, Laskowska, Aleksandra, Bębenek, Marek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941287/ http://dx.doi.org/10.1016/j.ejso.2022.11.549 |
Ejemplares similares
-
Cytoreductive Surgery and HIPEC for Peritoneal Carcinomatosis in the Elderly
por: Spiliotis, J. D., et al.
Publicado: (2014) -
Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
por: Cardi, Maurizio, et al.
Publicado: (2015) -
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis
por: Vassos, Nikolaos, et al.
Publicado: (2016) -
Management of recurrent cervical cancer with peritoneal carcinomatosis with HIPEC
por: Lantsman, Taliya, et al.
Publicado: (2021) -
Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)
por: Roy, Susmit Prosun, et al.
Publicado: (2022)